skip to content

Cambridge Cardiovascular

The Cambridge BHF Centre of Research Excellence and the Cardiovascular IRC have run a series of joint research symposia. These annual events are free to attend and open to all Cambridge Cardiovascular-area academic and clinical researchers. We host around 140 delegates across the University, hospitals, affiliated institutions, and industrial partners,
When Apr 29, 2021
from 10:30 AM to 06:20 PM
Where Online via Zoom
Contact Name
Attendees 140
Add event to calendar vCal


ABSTRACT BOOK (email us for a copy at


10.30- 11.30      Welcome

                           Poster presentations in themed break out rooms

12.00 – 12.10     Martin Bennett – Overview and progress of the CRE

SESSION 1          Population and Data Science (Chair John Danesh)

12.10 – 12.25     Emanuele Di Angelantonio, Cardiovascular disease risk prediction using UK Biobank

12.25–  12.40     Lisa Pennells, New developments in Cardiovascular disease risk scores

12.40 – 12.55     Praveen Surendran, Genetic study molecular phenotypes to understand complex disease aetiology           

SESSION 2        Functional Genomics (Chair Nicole Soranzo)

13.00 – 13.15     Seamus Harrison, Genomics of aortic diseases

13.15 – 13.30     Stefan Graf, Update on PAH genomics

13.30 – 13.45     Alex Granata, Modelling stroke using iPSCs

SESSION 3        Cardiometabolic Medicine (Chair Toni Vidal-Puig)

13.50 – 14.05     Julia Carrasco Zanini Sanchez, Studying the human plasma proteome at scale: from genes to disease

14.05 – 14.20     Dino Giussani, Heart Disease Link to Fetal Hypoxia

14.20 – 14.35     Ana Vujic, Benefits of Physical Exercise on the Aging heart

14.40-15.00     Break, Refreshments    

SESSION 4        Cardiovascular Medicine (Chair Ziad Mallat)

15.00 – 15.15     Jordi Lambert, Heterogeneity in vascular smooth muscle cell activation.

15.15 – 15.30     Xuan Li, Microtubule-dependent mechanism in controlling cardiomyocyte  contractility after myocardial infarction

15.30 – 15.45     Maria Colzani– Cardiovascular involvement in COVID-19

SESSION FIVE    Translation (Chair Ian Wilkinson)

15.50 – 16.05    Tian Zhao, Interleukin-2 in ischaemic heart disease: the use of scRNA-seq in drug development 

16.05 – 16.20    James Goodman, Cardiovascular Effects of GLP-1 and Glucagon Receptor Dual Agonism – New Insights

16.20 – 16.35    Li-ming Gan (AstraZeneca, Bioscience Cardiovascular) Microvascular inflammation in HFpEF

16.40– 17.20      Keynote speaker: Professor Aroon Hingorani (University College London),  Democratising cardiovascular drug development through human genomics

17.20 – 17.30     Closing words and abstract/poster prizes- Martin Bennett

17.30 – 18.30     Networking session in breakout rooms


Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.


We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Tammy Dougan

Cardiovascular Seminars at

Cambridge Cardiovascular on You Tube

Follow us on Twitter